Omnicell Revenue 2010-2024 | OMCL
Omnicell revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Omnicell Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $1,147 |
| 2022 | $1,296 |
| 2021 | $1,132 |
| 2020 | $892 |
| 2019 | $897 |
| 2018 | $787 |
| 2017 | $713 |
| 2016 | $696 |
| 2015 | $485 |
| 2014 | $441 |
| 2013 | $381 |
| 2012 | $314 |
| 2011 | $246 |
| 2010 | $222 |
| 2009 | $213 |
| Omnicell Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $282 |
| 2024-06-30 | $277 |
| 2024-03-31 | $246 |
| 2023-12-31 | $259 |
| 2023-09-30 | $299 |
| 2023-06-30 | $299 |
| 2023-03-31 | $291 |
| 2022-12-31 | $298 |
| 2022-09-30 | $348 |
| 2022-06-30 | $331 |
| 2022-03-31 | $319 |
| 2021-12-31 | $311 |
| 2021-09-30 | $296 |
| 2021-06-30 | $273 |
| 2021-03-31 | $252 |
| 2020-12-31 | $249 |
| 2020-09-30 | $214 |
| 2020-06-30 | $200 |
| 2020-03-31 | $230 |
| 2019-12-31 | $248 |
| 2019-09-30 | $229 |
| 2019-06-30 | $217 |
| 2019-03-31 | $203 |
| 2018-12-31 | $212 |
| 2018-09-30 | $204 |
| 2018-06-30 | $189 |
| 2018-03-31 | $183 |
| 2017-12-31 | $196 |
| 2017-09-30 | $187 |
| 2017-06-30 | $181 |
| 2017-03-31 | $149 |
| 2016-12-31 | $175 |
| 2016-09-30 | $177 |
| 2016-06-30 | $173 |
| 2016-03-31 | $171 |
| 2015-12-31 | $130 |
| 2015-09-30 | $125 |
| 2015-06-30 | $113 |
| 2015-03-31 | $116 |
| 2014-12-31 | $122 |
| 2014-09-30 | $113 |
| 2014-06-30 | $105 |
| 2014-03-31 | $102 |
| 2013-12-31 | $106 |
| 2013-09-30 | $94 |
| 2013-06-30 | $94 |
| 2013-03-31 | $87 |
| 2012-12-31 | $90 |
| 2012-09-30 | $84 |
| 2012-06-30 | $75 |
| 2012-03-31 | $64 |
| 2011-12-31 | $63 |
| 2011-09-30 | $64 |
| 2011-06-30 | $61 |
| 2011-03-31 | $57 |
| 2010-12-31 | $57 |
| 2010-09-30 | $56 |
| 2010-06-30 | $55 |
| 2010-03-31 | $54 |
| 2009-12-31 | $55 |
| 2009-09-30 | $54 |
| 2009-06-30 | $53 |
| 2009-03-31 | $52 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.043B | $1.147B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.263B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.580B | 174.01 |
| Hims & Hers Health (HIMS) | United States | $5.276B | 134.17 |
| Enovis (ENOV) | United States | $2.580B | 17.49 |
| Privia Health (PRVA) | United States | $2.530B | 210.80 |
| IRhythm Technologies (IRTC) | United States | $2.313B | 0.00 |
| Azenta (AZTA) | United States | $2.227B | 111.05 |
| Clover Health Investments (CLOV) | United States | $1.684B | 0.00 |
| 10x Genomics (TXG) | United States | $1.609B | 0.00 |
| Schrodinger (SDGR) | United States | $1.484B | 0.00 |
| Phreesia (PHR) | United States | $1.098B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
| Standard BioTools (LAB) | United States | $0.603B | 0.00 |
| Talkspace (TALK) | United States | $0.559B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.518B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.491B | 85.00 |
| Health Catalyst (HCAT) | United States | $0.466B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| TruBridge (TBRG) | United States | $0.239B | 69.61 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.077B | 0.00 |
| HeartBeam (BEAT) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.038B | 0.00 |
| Movano (MOVE) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.010B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |